Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Timing for rebalancing crypto portfolios depends on volatility, drift from targets, and your risk tolerance, with clear trigger rules.
19,022 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Hype around SpaceX can obscure solid growth opportunities. Here are two AI-driven stock picks that offer clearer earn...
When sandisk stock just dropped, it sent ripples through a volatile memory market. This article breaks down the drive...
SpaceX is eyed for Nasdaq-100 inclusion via a Fast Entry rule. Learn what it means for investors, how to evaluate the...
This guide spotlights four housing markets long-term with strong, durable growth potential, plus five markets growing...
Brokers are turning to AI-enabled property management as market forces slow home sales, embracing recurring revenue t...
IBM is quietly reshaping its story with a serious quantum strategy, strong enterprise demand, and a durable dividend....
Warren Buffett resurfaces on CNBC as Berkshire Hathaway shares retreat, highlighting leadership transition questions ...
A Monday surge put Archer Aviation stock in the spotlight as investors reacted to major eVTOL news. This guide breaks...
Two power players, two paths: Constellation Energy and Vistra offer differing mixes of stability and upside. This gui...
Broadcom sits at the crossroads of AI infrastructure and traditional networking. Here are three grounded predictions ...
Gold has rallied about 73% over the past year as inflation jitters fade and risk-off trades surge. This report shows ...